Kintegral Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $632K | Sell |
1,203
-3
| -0.2% | -$1.58K | 0.06% | 208 |
|
|
2025
Q1 | $765K | Sell |
1,206
-4
| -0.3% | -$2.54K | 0.08% | 192 |
|
|
2024
Q4 | $862K | Sell |
1,210
-57
| -4% | -$40.6K | 0.08% | 188 |
|
|
2024
Q3 | $1.33M | Sell |
1,267
-16
| -1% | -$16.8K | 0.12% | 156 |
|
|
2024
Q2 | $1.35M | Buy |
1,283
+601
| +88% | +$632K | 0.13% | 155 |
|
|
2024
Q1 | $656K | Sell |
682
-2
| -0.3% | -$1.93K | 0.07% | 196 |
|
|
2023
Q4 | $601K | Sell |
684
-4
| -0.6% | -$3.51K | 0.07% | 201 |
|
|
2023
Q3 | $566K | Hold |
688
| – | – | 0.07% | 196 |
|
|
2023
Q2 | $494K | Hold |
688
| – | – | 0.06% | 209 |
|
|
2023
Q1 | $565K | Sell |
688
-37
| -5% | -$30.4K | 0.07% | 195 |
|
|
2022
Q4 | $523K | Sell |
725
-239
| -25% | -$172K | 0.07% | 203 |
|
|
2022
Q3 | $664K | Hold |
964
| – | – | 0.09% | 178 |
|
|
2022
Q2 | $570K | Buy |
964
+21
| +2% | +$12.4K | 0.07% | 202 |
|
|
2022
Q1 | $659K | Buy |
943
+21
| +2% | +$14.7K | 0.07% | 201 |
|
|
2021
Q4 | $582K | Hold |
922
| – | – | 0.06% | 221 |
|
|
2021
Q3 | $558K | Hold |
922
| – | – | 0.07% | 219 |
|
|
2021
Q2 | $515K | Hold |
922
| – | – | 0.06% | 225 |
|
|
2021
Q1 | $436K | Hold |
922
| – | – | 0.06% | 238 |
|
|
2020
Q4 | $445K | Hold |
922
| – | – | 0.06% | 230 |
|
|
2020
Q3 | $516K | Sell |
922
-30
| -3% | -$16.8K | 0.08% | 196 |
|
|
2020
Q2 | $594K | Hold |
952
| – | – | 0.1% | 181 |
|
|
2020
Q1 | $465K | Buy |
952
+107
| +13% | +$52.3K | 0.09% | 189 |
|
|
2019
Q4 | $317K | Hold |
845
| – | – | 0.06% | 251 |
|
|
2019
Q3 | $234K | Hold |
845
| – | – | 0.05% | 264 |
|
|
2019
Q2 | $264K | Hold |
845
| – | – | 0.05% | 264 |
|
|
2019
Q1 | $347K | Buy |
845
+37
| +5% | +$15.2K | 0.07% | 232 |
|
|
2018
Q4 | $302K | Buy |
+808
| New | +$302K | 0.09% | 185 |
|